A History of Cancer: From Ancient Treatments to Modern Medicine

Cancer has been documented since antiquity, with treatment evolving from mystical remedies to precision medicine.

Ancient & Pre‑Modern Era

• Egypt (1600 BCE): Edwin Smith Papyrus describes breast tumors; treated with cauterization, herbal poultices.
• Greece/Rome: Hippocrates named “karkinos” (crab); Galen attributed to black bile excess. Surgery (amputation) attempted.
• Middle Ages: Viewed as divine punishment; little progress.
• Renaissance (1500s): Paracelsus proposed a “seed” spreading—early metastasis concept.

19th Century Breakthroughs

• Anesthesia (1846) and antisepsis (Lister, 1867) made surgery viable.
• Halsted radical mastectomy (1882) – standard for 70+ years.
• X‑rays (1895, Röntgen) → radiation therapy (Grubbe, 1896).

20th Century: Systemic Therapies

• 1940s: Nitrogen mustard (first chemo) for lymphoma.
• 1950s: Methotrexate (first cure of metastatic choriocarcinoma).
• 1960s: Hormonal therapy (tamoxifen for breast cancer).
• 1970s: Combination chemo (MOPP, CMF) cures Hodgkin lymphoma, breast cancer.
• 1990s: Targeted therapy begins (rituximab anti‑CD20, trastuzumab HER2).

21st Century: Precision & Immunotherapy

• Immunotherapy: Checkpoint inhibitors (anti‑PD‑1/PD‑L1, CTLA‑4), CAR‑T cells.
• Genomic profiling: Match mutations to targeted drugs (EGFR, ALK, BRAF, etc.).
• Liquid biopsy: ctDNA for monitoring.
• Personalized vaccines, AI‑driven drug discovery.

Conclusion

From “black bile” to biomarker‑driven therapy, cancer treatment has transformed. Survival rates have doubled since the 1970s. Challenges remain: access, resistance, rare cancers, survivorship care.